Company Overview of MedImmune, LLC
MedImmune, LLC, a biologics research and development company, researches, develops, and explores medicines for unmet medical needs across therapeutic areas, including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines worldwide. It offers Synagis (palivizumab), a monoclonal antibody to prevent serious lower respiratory tract disease; FluMist Quadrivalent (Influenza Vaccine Live, Intranasal), a quadrivalent influenza vaccine; and Trivalent FluMist (T/LAIV), a live attenuated influenza vaccine. The company was incorporated in 1987 and is based in Gaithersburg, Maryland with locations in Mountain View, Santa Clar...
One MedImmune Way
Gaithersburg, MD 20878
Founded in 1987
Key Executives for MedImmune, LLC
Vice President of Finance
Vice President, Head of Antibody Discovery and Protein Engineering and Global Head of Technology
Senior Vice President of Biopharmaceutical Development
Compensation as of Fiscal Year 2015.
MedImmune, LLC Key Developments
Medimmune Appoints Christopher Rhodes as Head of Cardiovascular, Metabolic Disease Research
Jul 14 15
MedImmune announced that Christopher Rhodes, Ph.D., has joined the company as Vice President, Cardiovascular and Metabolic Disease (CVMD) Research. Dr. Rhodes will be responsible for developing and growing MedImmune's research base in CVMD in both the US and UK, and contributing to the product development goals and vision across the CVMD therapeutic area. Dr. Rhodes joins MedImmune from the University of Chicago, where he was Research Director at the Kovler Diabetes Center, the Kovler Family Professor of Endocrinology, and Chair of the Committee on Molecular Metabolism & Nutrition and Biomedical Sciences Cluster of the Biological Sciences Division.
MedImmune, LLC Presents at BIO International Convention 2015, Jun-16-2015 02:30 PM
Jun 11 15
MedImmune, LLC Presents at BIO International Convention 2015, Jun-16-2015 02:30 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.
MedImmune, LLC Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM
May 17 15
MedImmune, LLC Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States. Speakers: Reginald Seeto, Head of Partnering & Strategy and Vice President.
Similar Private Companies By Industry
Recent Private Companies Transactions